Caitong International Asset Management »

An2 Therapeutics shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.9k 2.6k 3.42

More positions owned by Caitong International Asset Management

Lumentum Hldgs (LITE)
Axt (AXTI)
Venture Global Com Cl A (VG)
Marvell Technology (MRVL)
Palantir Technologies Cl A (PLTR)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Exxon Mobil Corporation (XOM)
CF Industries Holdings (CF)
Cheniere Energy Com New (LNG)
Petroleo Brasileiro S A Sp Adr Non Vtg (PBR.A)
Lam Research Corp Com New (LRCX)
Chevron Corporation (CVX)
SLB Com Stk (SLB)
Visa Com Cl A (V)
Apple (AAPL)

View all positions for Caitong International Asset Management

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
Almitas Capital
Vanguard Group
Vanguard Capital Management
Woodline Partners
Ameriprise Financial
Stonepine Capital Management
Ally Bridge Group
Bank of Nova Scotia
Bank of America Corporation
Renaissance Technologies
BlackRock
Jane Street

View all funds holding An2 Therapeutics